Nordicus Partners NORD
OTC NORD
$4.02 -0.02 (-0.50%)
At close: Oct 20, 2026 · 4:00 PM EDT

Nordicus Partners (NORD) Cash from Financing Activities (2011 - 2026)

Updated

Nordicus Partners' Cash from Financing Activities came in at $145,750 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 64.4% from $409,970 a year earlier and down 71.2% from the prior quarter.

Analysis

Nordicus Partners (NORD) Cash from Financing Activities (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Nordicus Partners reported Cash from Financing Activities of $4.07 million, up 184.7% year-over-year; for FY2026 (ended Mar 31, 2026), it was $4.34 million, up 301.5% from FY2025.

  • Cash from Financing Activities has increased in each of the last three fiscal years.
  • Going back by fiscal year, Cash from Financing Activities was $1.08 million in FY2025 (+253.8%), $305,225 in FY2024 (+136.8%), $128,886 in FY2023 (-67.8%) and $400,000 in FY2022.
  • The fiscal Q1 2027 figure represents the lowest quarterly Cash from Financing Activities since fiscal Q1 2025.
  • Year-over-year, Cash from Financing Activities increased in seven of the last eight quarters, with growth averaging 271.0%.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in fiscal Q1 2026 (growth of 583.3%), and the weakest in fiscal Q1 2027 (a decline of 64.4%).
  • Business Quant data shows NORD's Cash from Financing Activities at $506,876 (Q4 2026), $1.41 million (Q3 2026) and $2.01 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -8.53 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -5.05 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -3.89 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 2.34 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -3.66 Bn
10 Nordicus Partners 78.16 Mn 77.63 Mn - 145,750.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 145,750.00
Mar 31, 2026 506,876.00
Dec 31, 2025 1.41 Mn
Sep 30, 2025 2.01 Mn
Jun 30, 2025 409,970.00
Mar 31, 2025 313,477.00
Dec 31, 2024 319,120.00
Sep 30, 2024 387,330.00
Jun 30, 2024 60,000.00
Mar 31, 2024 114,365.00
Dec 31, 2023 83,936.00
Sep 30, 2023 81,924.00
Jun 30, 2023 25,000.00
Mar 31, 2023 230,236.00
Dec 31, 2022 40,000.00
Mar 31, 2022 200,000.00
Jun 30, 2020 -5.09 Mn
Mar 31, 2020 -1,000.00
Dec 31, 2019 65,000.00
Jun 30, 2019 -15,000.00
API Access

Nordicus Partners Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NORD&period=max&api_key=YOUR_API_KEY